The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis
Abstract
BACKGROUND: Renal impairment increases the risk of stroke and bleeding in patients with atrial fibrillation. In the Randomized Evaluation of Long-Term Anticoagulant Therapy (RELY) trial, dabigatran, with ≈80% renal elimination, displayed superiority over warfarin for prevention of stroke and systemic embolism in the 150-mg dose and significantly less major bleeding in the 110-mg dose in 18 113 patients with nonvalvular atrial fibrillation. This prespecified study investigated these outcomes in relation to renal function. METHODS AND RESULTS: Glomerular filtration rate was estimated with the Cockcroft-Gault, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), and Modification of Diet in Renal Disease (MDRD) equations in all randomized patients with available creatinine at baseline (n=17 951), and cystatin C-based glomerular filtration rate was estimated in a subpopulation with measurements available (n=6190). A glomerular filtration rate ≥80, 50 to <80, and <50 mL/min was estimated in 32.6%, 47.6%, and 19.8% and in 21.6%, 59.6%, and 18.8% of patients based on Cockcroft-Gault and CKD-EPI, respectively. Rates of stroke or systemic embolism, major bleeding, and all-cause mortality increased as renal function decreased. The rates of stroke or systemic embolism were lower with dabigatran 150 mg and similar with 110 mg twice daily compared with warfarin, without significant heterogeneity in subgroups defined by renal function (interaction P>0.1 for all). For the outcome of major bleeding, there were significant interactions between treatment and renal function according to CKD-EPI and MDRD equations, respectively (P<0.05). The relative reduction in major bleeding with either dabigatran dose compared with warfarin was greater in patients with glomerular filtration rate ≥80 mL/min. CONCLUSIONS: The efficacy of both dosages of dabigatran was consistent with the overall trial irrespective of renal function. However, with the CKD-EPI and MDRD equations, both dabigatran dosages displayed significantly lower rates of major bleeding in patients with glomerular filtration rate ≥80 mL/min. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT00262600.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Renal clearance”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [425]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Self-citationRivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Self-citationGuidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Levey, A. S., Coresh, J., Greene, T., Marsh, J., Stevens, L. A., Kusek, J. W., & Lente, F. V. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077180 · Cited by 1,854
Cited by
Sorted by citations
Items 201–300 of 395
Vornicu, O., Larock, A., Dincq, A.-S., Douxfils, J., Dogné, J., Mullier, F., & Lessire, S. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1349749 · Cited by 10
Impact of different renal function equations on direct oral anticoagulant concentrations
Lin, S., Kuo, C., Huang, T., Peng, Y., Huang, C., Tang, S., & Jeng, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-03318-4 · Cited by 10
Bundhun, P. K., Chaudhary, N., & Yuan, J. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0511-8 · Cited by 10
Altawalbeh, S. M., Alshogran, O. Y., & Smith, K. J. (2018) · Value in Health · doi:10.1016/j.jval.2018.06.009 · Cited by 10
Gui, Y.-Y., Zou, S., Yang, W., Gong, S., Cen, Z., Xie, Z., & Cui, K.-J. (2019) · Medicine · doi:10.1097/md.0000000000018205 · Cited by 10
Cayuelas, J. M. A., Pastor‐Pérez, F. J., Puche, C. M., Mateo-Martínez, A., Garcı́a-Alberola, A., Flores‐Blanco, P. J., Valdés, M., Lip, G. Y. H., Roldán, V., & Manzano‐Fernández, S. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.06.021 · Cited by 10
Akao, M., Yamashita, T., Suzuki, S. S., & Okumura, K. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.02.007 · Cited by 10
Kocjan, M., Kosowski, M., Mazurkiewicz, M., Muzyk, P., Nowakowski, K., Kawecki, J., Morawiec, B., & Kawecki, D. (2024) · Biomedicines · doi:10.3390/biomedicines12102242 · Cited by 9
Masunaga, N., Ishii, M., Oka, K., Okamoto, K., Yoshida, Y., Minami, K., Ishigami, K., Doi, K., Hamatani, Y., Yoshizawa, T., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-24-0614 · Cited by 10
Russo, V., Rago, A., Proietti, R., Attena, E., Rainone, C., Crisci, M., Papa, A. A., Calabrò, P., D’Onofrio, A., Golino, P., et al. (2019) · BioMed Research International · doi:10.1155/2019/5473240 · Cited by 9
Michlicka, W., Kalarus, Z. F., Podolecki, T., Mitręga, K. A., & Streb, W. (2022) · Advances in Interventional Cardiology · doi:10.5114/aic.2022.115319 · Cited by 9
Martínez‐Rubio, A., & Martínez-Torrecilla, R. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.07.017 · Cited by 9
Cayuelas, J. M. A., Pastor‐Pérez, F. J., Puche, C. M., Mateo-Martínez, A., Garcı́a-Alberola, A., Flores‐Blanco, P. J., Valdés, M., Lip, G. Y. H., Roldán, V., & Manzano‐Fernández, S. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.06.022 · Cited by 9
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
Mukhin, N. A., Glybochko, P. V., Svistunov, A. A., Fomin, V., & Kiyakbaev, G. G. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh20168864-8 · Cited by 9
Minno, M. N. D. D., Ambrosino, P., Minno, A. D., Tremoli, E., & Minno, G. D. (2017) · Annals of Medicine · doi:10.1080/07853890.2016.1268710 · Cited by 9
Lip, G. Y. H., Al‐Saady, N., Ezekowitz, M. D., Banach, M., & Goette, A. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.07.010 · Cited by 9
Self-citationXu, Y., Bechler, K., Callahan, A., & Shah, N. H. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104420 · Cited by 9
Lee, A., & Rajaratnam, R. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000248 · Cited by 8
Use of DOACs in real-world challenging settings: a Delphi Consensus from Italian cardiologists
Rossini, R., Quadri, G., Rognoni, A., Nardi, F., Varbella, F., & Musumeci, G. (2019) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.19.04985-5 · Cited by 8
Navas‐Blanco, J. R., Martini, A., & Fabbro, M. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.02.024 · Cited by 9
Lee, J., Joung, B., Cha, M., Lee, J. H., Lim, W., Kim, T., Shin, S. Y., Uhm, J., Lim, H. E., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.87 · Cited by 8
Ramagopalan, S. V., Stamp, E., Sammon, C., Besford, M., Carroll, R., Mehmud, F., & Alikhan, R. (2019) · Future Cardiology · doi:10.2217/fca-2019-0012 · Cited by 8
Use of direct oral anticoagulants in ICU patients. Part I – Applied pharmacology
Wahab, A., Patnaik, R., & Gurjar, M. (2021) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2021.110607 · Cited by 8
Dzeshka, M. S., & Lip, G. Y. H. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.973847 · Cited by 8
Association between Renal Function and Bleeding Risk for Dabigatran after Switching from Warfarin
Kalil, R. S., Kaboli, P. J., Liu, X., & Vaughan‐Sarrazin, M. (2016) · American Journal of Nephrology · doi:10.1159/000446848 · Cited by 8
Huqi, A., Zoccali, C., Giugliano, R. P., & Caterina, R. D. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac450 · Cited by 8
Lee, K. H., Joung, B., Lee, S., Hwang, Y. M., Park, J., Baek, Y., Park, Y. M., Park, J., Park, H. C., Park, H. W., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.110 · Cited by 7
Anticoagulación oral en la enfermedad renal crónica con fibrilación auricular
Gómez-Fernández, P., Santana, A. M., & Barrionuevo, J. D. D. A. (2020) · Nefrología · doi:10.1016/j.nefro.2020.08.007 · Cited by 7
Binding, C., Blanche, P., Lip, G. Y. H., Kamper, A., Lee, C. J., Stærk, L., Gislason, G., Torp-Pedersen, C. T., Olesen, J. B., & Bonde, A. N. (2024) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvae016 · Cited by 7
Safety of low-dose dabigatran in patients with atrial fibrillation and mild renal insufficiency
Fukaya, H., Niwano, S., Oikawa, J., Nishinarita, R., Horiguchi, A., Nakamura, H. K., Fujiishi, T., Igarashi, T., Ishizue, N., Yoshizawa, T., et al. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.05.011 · Cited by 7
Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
Alings, M. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016.20.3 · Cited by 7
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction
Mahmood, M., & Lip, G. Y. H. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.05.015 · Cited by 7
Comment et chez qui faut-il surveiller les traitements anticoagulants ?
Smadja, D. M., Gendron, N., & Sanchez, O. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.06.002 · Cited by 7
Jang, S. M., Bahjri, K. A., & Tran, H. N. (2020) · Pharmacy · doi:10.3390/pharmacy8010030 · Cited by 9
Zhao, S., Hong, X., Cao, J., Cai, H., Du, S., & Ma, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01293 · Cited by 9
Grandone, E., Aucella, F., Barcellona, D., Brunori, G., Forneris, G., Gresele, P., Marietta, M., Poli, D., Testa, S., Tripodi, A., et al. (2020) · Blood transfusion · doi:10.2450/2020.0156-20 · Cited by 7
Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant
Minhas, A., Jiang, Q., Gu, X., Haymart, B., Kline-Rogers, E. M., ALMANY, S. L., Kozłowski, J., Krol, G. D., Kaatz, S. S., Froehlich, J. B., et al. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1377-9 · Cited by 7
Dabigatran in nonvalvular atrial fibrillation
Mumoli, N., Mastroiacovo, D., Permunian, E. T., Vitale, J., Giorgi‐Pierfranceschi, M., Cei, M., & Dentali, F. (2017) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000524 · Cited by 7
Fabbro, M., Dunn, S. A., Rodriguez‐Blanco, Y. F., & Jain, P. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.07.023 · Cited by 7
Wang, H., Li, K., Li, J., Lin, K., Shi, Y., Wang, H., Si, Q., & Wang, Y. (2019) · Journal of International Medical Research · doi:10.1177/0300060519858151 · Cited by 7
Xu, R., Wu, F., Lan, J., & Duan, P. (2021) · Expert Review of Hematology · doi:10.1080/17474086.2021.1920012 · Cited by 7
Zhou, B., Wu, H., Wang, C., Lou, B., & She, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.700740 · Cited by 7
Molteni, M., Bo, M., Minno, G. D., Pasquale, G. D., Genovesi, S., Toni, D., & Verdecchia, P. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1660-6 · Cited by 7
DOAC use in patients with chronic kidney disease
Kcükköylü, S., & Rump, L. C. (2017) · Hämostaseologie · doi:10.5482/hamo-17-01-0003 · Cited by 7
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2014.07.001 · Cited by 6
Avances en el tratamiento anticoagulante de la fibrilación auricular
Olmedo, M., & Fernández, C. S. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.07.018 · Cited by 6
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Gremmel, T., Niessner, A., Domanovits, H., Frossard, M., Sengölge, G., Steinlechner, B., Sycha, T., Wolzt, M., & Pabinger, I. (2018) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1381-5 · Cited by 5
Bhatia, H. S., Bailey, J., Ünlü, O., Hoffman, K., & Kim, R. J. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13811 · Cited by 6
Time in Therapeutic Range for Dialysis Patients on Warfarin
Niznik, R. S., Hoel, R. W., Vaughan, L. E., Majorowicz, R. R., & Albright, R. C. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.02.030 · Cited by 6
Direct oral anticoagulants across the heart failure spectrum: the precision medicine era
Paolillo, S., Ruocco, G. M., Filardi, P. P., Palazzuoli, A., Tocchetti, C. G., Nodari, S., Lombardi, C., Metra, M., Correale, M., & on behalf of “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09994-0 · Cited by 6
Chugh, Y., Gupta, K., Krishna, H. B., Ayala, R. Q., Zepeda, I. A., Grushko, M. J., & FAILLACE, R. T. (2022) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14623 · Cited by 6
Navalha, D. D. P., Felix, N. S., Nogueira, A., Clemente, M. R. C., Marinho, A. D., Ferreira, R. O. M., Pasqualotto, E., Dagostin, C. S., Pinto, L. C. S., & Fernandes, G. C. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03889-3 · Cited by 6
Zaitoun, M. F., Sheikh, M. E., Faifi, A. S. A., Mahedy, A. W., Nazer, W. E., & Hennawy, H. M. E. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.09.042 · Cited by 6
Cline, L., Generoso, E. M. G., D’Apice, N., Dellinger, S. K., Tovey, A., Clark, N. P., Nui, F., Hui, R. L., Hale, S. A., Ramsey, T., et al. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02758-7 · Cited by 6
Simpson, B. H., Reith, D. M., Medlicott, N. J., & Smith, A. J. (2018) · TH Open · doi:10.1055/s-0038-1676356 · Cited by 6
Recent evidence for direct oral anticoagulants in chronic kidney disease
Ha, J. T. K., Badve, S. V., & Jun, M. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000493 · Cited by 6
Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation
Dahdaleh, S., & Malhotra, P. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0553-6 · Cited by 4
Direct oral anticoagulants: a practical guide for the emergency physician
Hogg, K. E., Panag, A., Worster, A., & Thachil, J. V. (2016) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000000400 · Cited by 6
Chao, T., D, E. B. M., Palazzolo, M. G., Antman, E. M., Carnicelli, A., Eikelboom, J. W., Granger, C. B., Goto, S., Kato, E. T., Lip, G. Y. H., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag246 · Cited by 5
Self-citationTerceño, M., Silva, Y., Bashir, S., Vera-Monge, V. A., Buxó, M., & Serena, J. L. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.104528 · Cited by 5
Rottenkolber, M., Schmiedl, S., Ibáñez, L., Sabaté, M., Ballarín, E., Vidal, X., León-Muñoz, L. M., Huerta, C., Martín‐Merino, E., Montero, D., et al. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13517 · Cited by 5
de Vries, T. I., Stam‐Slob, M. C., Peters, R. J. G., van der Graaf, Y., Westerink, J., & Visseren, F. L. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.017605 · Cited by 5
Perreault, S., Boivin‐Proulx, L., Lenglet, A., Massy, Z. A., & Dorais, M. (2023) · World Journal of Nephrology · doi:10.5527/wjn.v12.i5.132 · Cited by 5
Martínez‐Rubio, A., & Martínez-Torrecilla, R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.07.016 · Cited by 5
Diogo, C. V., Duarte, J. D. O. M., Sobral, S., Pestana, P., Nzwalo, H., Rita, H. J. B., & Costa, J. S. E. (2014) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2014.04.021 · Cited by 5
Tomaszuk−Kazberuk, A., Kołtowski, Ł., Balsam, P., Koziński, M., Kapłon‐Cieślicka, A., Kupczyńska, K., Domienik‐Karłowicz, J., Budaj‐Fidecka, A., Buszman, P. P., Wybraniec, M. T., et al. (2018) · Cardiology Journal · doi:10.5603/cj.2018.0080 · Cited by 5
Tanaka, A., Suzuki, M., Matsunaga, K., Taguchi, I., Nakahara, S., Chihara, A., Oyama, J., & Node, K. (2020) · Hypertension Research · doi:10.1038/s41440-019-0384-6 · Cited by 5
Michal, M., Eggebrecht, L., Göbel, S., Panova‐Noeva, M., Nagler, M., Arnold, N., Lauterbach, M., Bickel, C., Wiltink, J., Beutel, M. E., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz085 · Cited by 5
Xiong, Y., Hu, L., Zhou, W., Li, M., Wang, T., Huang, X. B., Bao, H., & Cheng, X. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620910808 · Cited by 5
Wang, Z., Xiang, Q., Hu, K., Zhang, X., Xie, Q., Liu, Z., & Cui, Y. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00469-7 · Cited by 5
Kucey, M., Bolt, J., Albers, L., Bell, A., Iroh, N., & Toppings, J. (2016) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v69i5.1596 · Cited by 5
Camm, A. J., & Atar, D. (2021) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721665 · Cited by 6
Launay‐Vacher, V., Scotté, F., Riess, H. B., Ashman, N., McFarlane, P. A., Ribic, C. M., & Elalamy, I. (2018) · Journal of Onco-Nephrology · doi:10.1177/2399369318809102 · Cited by 5
dos Santos, S. M., & Harder, S. (2014) · Drug Safety · doi:10.1007/s40264-014-0151-1 · Cited by 4
Monteiro, J. M. C., San-Martin, D. L., Silva, B. C. G., Souza, I. F. B., Filho, J. O., & Jesus, P. A. (2019) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20190005 · Cited by 4
Ferner, R. E., & Aronson, J. K. (2024) · Drug Safety · doi:10.1007/s40264-024-01428-2 · Cited by 4
Ersoy, İ. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211038685 · Cited by 4
Liao, J., Kuo, L., Liu, C., Chen, S., & Chao, T. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartj/suab154 · Cited by 4
Stroke Prevention in Atrial Fibrillation
Szapáry, L. B. (2015) · Journal of Clinical Trials in Cardiology · doi:10.15226/2374-6882/2/4/00132 · Cited by 4
Обрезан, А. Г., & Zemchenkov, A. Y. (2018) · Kardiologiia · doi:10.18087/cardio.2018.4.10111 · Cited by 4
Chin, P. K. L., Wright, D. F. B., & Florkowski, C. M. (2014) · Circulation · doi:10.1161/circulationaha.114.010099 · Cited by 4
Rubboli, A., Fresco, C., Paciaroni, M., Rocca, B., Pecora, D., Enea, I., Cuccia, C., & Patti, G. (2021) · PubMed · doi:10.2459/jcm.0000000000001204 · Cited by 3
Menichelli, D., Gazzaniga, G., Poli, D., Palareti, G., Antonucci, E., Pani, A., Pignatelli, P., Pastori, D., The START2 Register Investigators, Cosmi, B., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02765-7 · Cited by 3
Use of Direct Oral Anticoagulants in Special Populations
Li, A., Lópes, R. D., & Garcia, D. A. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.05.003 · Cited by 3
Li, X., Zuo, C., Ji, Q., Wang, Z., & Lv, Q. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.762872 · Cited by 3
Atrial fibrillation: focus on monitoring strategies after cryptogenic stroke
BUONO, M. G. D., & SANNA, T. (2022) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.21.05851-8 · Cited by 3
Montomoli, M., Roca, L., Rivera, M., Fernández-Prado, R., Redondo, B., Camacho, R., Peregrin, C. M., Pampa, S., González, A., Todolí, J. C., et al. (2022) · Healthcare · doi:10.3390/healthcare10122566 · Cited by 3
Patel, M. R., Peacock, W. F., Tamayo, S. G., Sicignano, N., Hopf, K. P., & Yuan, Ž. (2018) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.17.216 · Cited by 3
Shen, N., Zhang, X., Le, K.-J., Wei, A., Wu, Y., & Gu, Z. (2019) · Medicine · doi:10.1097/md.0000000000016194 · Cited by 3
Huqi, A., Zoccali, C., Giugliano, R. P., & Caterina, R. D. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107123 · Cited by 3
Park, J., Kim, J., Baek, Y., Lee, S., Hwang, Y. M., Kim, T.-H., Lee, D. I., Lee, K. H., Shim, J., & Joung, B. (2019) · Korean Journal of Medicine · doi:10.3904/kjm.2019.94.1.17 · Cited by 3
van der Wall, S. J., Teutsch, C., Dubner, S., Diener, H., Halperin, J. L., Sheng, C., Rothman, K. J., Paquette, M., Zint, K., França, L. R., et al. (2021) · TH Open · doi:10.1055/s-0040-1722706 · Cited by 3
Larina, V. N., Oynotkinova, O. S., Majorova, A. P., Egiazarian, G. A., & Demidova, T. Y. (2021) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2021-06-05 · Cited by 3
Latif, F., Meer, K. K., SHAIKH, Z., Mubbashir, A., Umar, K. H. A. N., Usmani, T. F., Alvares, J., Imran, M., Shahid, A., Shaikh, A. W., et al. (2024) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.24.06564-5 · Cited by 2
Diretriz Brasileira de Fibrilação Atrial – 2025
Cintra, F. D., Pisani, C. F., Rezende, A. G. D. S., Henz, B. D., Armaganijan, L., Pimentel, M., Lópes, R. D., do Nascimento, T. A., Lorga-Filho, A. M., de Albuquerque, A., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250618 · Cited by 21
Pengo, V., Marongiu, F., & Barcellona, D. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2025_785 · Cited by 2
Anticoagulation in Elderly Patients With Chronic Kidney Disease: How Safe Is It?
McMurtry, M. S., & Cairns, J. A. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.05.016 · Cited by 2
New aspects of anticoagulant therapy in atrial fibrillation in patients with renal dysfunction
Кобалава, Ж. Д., Lazarev, P. V., & Vatsik-Gorodetskaya, M. V. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4175 · Cited by 2
The risk of bleeding minimization with direct oral anticoagulants
Novikova, Т. N. (2021) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2021-11-1-106-126 · Cited by 2
Pickett, J. D. (2019) · Critical Care Nurse · doi:10.4037/ccn2019292 · Cited by 2
Metadata
- Authors
- Hijazi, Z., Hohnloser, S. H., Oldgren, J., Andersson, U., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Reilly, P. A., Siegbahn, A., Yusuf, S., & Wallentin, L.
- Affiliations
- Goethe University Frankfurt (DE)
- ORCID
- Venue
- Circulation
- Published
- 2014-03-04
- Volume
- 129
- Issue
- 9
- Pages
- 961-970
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2026766534
- Cited by
- 396
- References
- 27
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 20 · 2023: 8 · 2022: 22 · 2021: 34 · 2020: 34 · 2019: 40 · 2018: 59 · 2017: 45 · 2016: 47 · 2015: 48 · 2014: 27
- FWCI
- 27.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- dabigatran, warfarin, atrial fibrillation, renal dysfunction, glomerular filtration rate, stroke prevention, systemic embolism, major bleeding, all-cause mortality, CKD-EPI, MDRD equation, Cockcroft-Gault, cystatin C, non-valvular atrial fibrillation, anticoagulation
- MeSH terms
- Dabigatran, Aged, Aged, 80 and over, Anticoagulants, Atrial Fibrillation, Benzimidazoles, Dose-Response Relationship, Drug, Embolism, Female, Glomerular Filtration Rate, Humans, Kidney, Male, Middle Aged, Models, Biological, Risk Factors, Warfarin, beta-Alanine, Treatment Outcome, Stroke, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
